Thursday, November 20, 2025

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Canadian Copper Set To Submit Environmental Impact Assessment In H1 2026 For Murray Brook

Related News

President Trump’s Social Media SPAC Could Now Have Interesting Risk-Reward Characteristics

Former U.S. President Donald Trump’s SPAC stock, Digital World Acquisition Corp. (NASDAQ: DWAC), has reversed...

Friday, November 26, 2021, 03:39:00 PM

Did Intel Just Give Away 10% Stake To White House For Free?

Intel (NASDAQ: INTC) agreed to a roughly 10% US government stake—structured as a negotiated equity-for-funding...

Monday, August 25, 2025, 12:57:00 PM

Why Trump’s Latest ‘Public Offering’ Pitch for Fannie and Freddie Is All Smoke and Mirrors

President Donald Trump’s recent post proclaiming he’s “giving very serious consideration to bringing Fannie Mae...

Thursday, May 22, 2025, 11:38:00 AM

Trump Slashes Energy & Mining Permitting Timelines Down To 28 Days

President Donald Trump has directed the Department of the Interior to cut permitting timelines for...

Friday, April 25, 2025, 11:31:00 AM

Kevin O’Leary and Grant Cardone Opt Out Of New York After Donald Trump’s $355 Million Fraud Verdict

Former FTX spokesperson and “Shark Tank” investor Kevin O’Leary has a lot of feelings about...

Thursday, February 22, 2024, 11:01:00 AM